{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRKK2",
        "Protein_Change": {
          "ref": "Y",
          "alt": "C",
          "position": "1699"
        },
        "variant_string_id": "LRKK2 Y1699C"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The disease mechanism is not explicitly defined in the paper",
          "judgment": "No",
          "reasoning": "The paper does not provide a clear definition of the disease's molecular basis or how the LRKK2 protein functions within that mechanism."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The general class of assay used is a yeast two-hybrid assay, which models protein-protein interactions",
          "judgment": "Yes",
          "reasoning": "Yeast two-hybrid assays are commonly used in the field of molecular biology to investigate protein-protein interactions and have been widely validated as effective tools for studying such interactions.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The specific instance of the assay has not been broadly accepted historically or previously validated in other studies, and no commercial kit with defined performance metrics is mentioned",
          "judgment": "No",
          "reasoning": "The absence of historical acceptance, previous validation, or commercial kit references suggests that this specific instance of the yeast two-hybrid assay may not meet the criteria for being considered an accepted or validated assay.",
          "next_step_or_outcome": "Do not use PS3/BS3"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "N/A"
      },
      "overall_conclusion": "Based on the lack of a clear disease mechanism definition, and the unvalidated nature of the specific instance of the yeast two-hybrid assay, functional evidence for the LRKK2 Y1699C variant cannot be assessed using the ACMG functional evidence evaluation flowchart."
    }
  ]
}